Sun Pharma Update by Epic Research

Sun Pharma   and Merck sign exclusive drug licensing agreement

Sun Pharma, Merck agreement for Merck’s skin ailment drug Tildrakizumab

Sun Pharma to pay USD 80 million for worldwide rights for Merck’s drug

Sun Pharma to fund development and regulatory activities for Tildrakizumab

Real Time News & Trading Trends Keep Liking Epic Research Private Limited

Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co